PROAIR DIGIHALER
SABA MDI
Albuterol sulfate · Teva Pharmaceuticals
Active Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per inhalation
Short-acting beta2-adrenergic agonist. Activates beta2-receptors on airway smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation (onset 5–15 minutes, duration 4–6 hours).
FDA-Approved Dosing by Indication
// approval varies by strength + age Asthma
1/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 90 mcg | Patients ≥4 years | 2 inhalations every 4–6 hours as needed Treatment or prevention of bronchospasm in patients ≥4 years with reversible obstructive airway disease. | As needed; 1 inhalation may suffice in some patients | FDA Approved |
Exercise-Induced Bronchospasm
1/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 90 mcg | Patients ≥4 years | 2 inhalations 15–30 minutes before exercise Prevention of exercise-induced bronchospasm. | As needed | FDA Approved |